AOD-9604 Explained: Can a Growth Hormone Fragment Burn Fat?

AOD-9604 is often marketed as the “fat-burning fragment” of human growth hormone. But what does it actually do, and did it work in human obesity trials?

In this episode of Peptides Explained, John Garrett, RN, breaks down:

• What AOD-9604 is and how it differs from full-length HGH

• Lipolysis, lipogenesis, and beta-3 adrenergic signaling

• Why animal studies looked promising

• What the early human trials showed

• Why the obesity-development program was discontinued

• Whether AOD-9604 raises IGF-1

• Regulatory status, risks, unknowns, and anti-doping concerns

• A responsible framework for evaluating experimental fat-loss peptides

The central takeaway: AOD-9604 has a plausible preclinical mechanism, but the available human evidence does not establish dependable, clinically meaningful fat loss.

This episode is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any therapy.

This episode is brought to you by Offline Peptides. If you are interested in Research Peptides Learn more at

PeptidesExplained.info/OfflinePeptides.

For more information about Peptide Solutions, visit Peptide-Solutions.info.

Send your 2–3 minute N=1 video to john@peptidesexplained.info.